首页 | 本学科首页   官方微博 | 高级检索  
     

脂肪干细胞HLA分子表达与体外抑制淋巴细胞增殖的实验研究
引用本文:Cui L,Yin S,Yang P,Liu B,Zhang Y,Liu W,Cao YL. 脂肪干细胞HLA分子表达与体外抑制淋巴细胞增殖的实验研究[J]. 中华医学杂志, 2005, 85(27): 1890-1894
作者姓名:Cui L  Yin S  Yang P  Liu B  Zhang Y  Liu W  Cao YL
作者单位:200011,上海第二医科大学第九人民医院整复外科,上海组织工程研究与开发中心
基金项目:国家高技术研究发展计划(863计划)课题资助项目(2001AA216021,2002AA205011),上海市重点学科及上海市重点实验室基金资助项目
摘    要:目的研究脂肪干细胞(adiposederivedstemcells,ADSCs)表面免疫分子的表达以及体外调节淋巴细胞反应的功能,以期为组织工程提供同种异体种子细胞来源。方法从临床脂肪抽吸术丢弃脂肪组织中分离获取脂肪干细胞(共3例),体外培养至第2代,流式细胞仪检测免疫分子HLAI、HLAII的表达。1×105个/孔ADSC细胞刺激异体淋巴细胞,观察细胞增殖情况。以植物血凝素(PHA,2μg/ml)刺激淋巴细胞后,分别以(1×102、1×103、1×104、1×105)细胞/孔数量的异体脂肪干细胞加入反应体系中,观察淋巴细胞增殖情况;另一组在刺激同时加入白介素2(IL2,0.5ng/ml),检测脂肪干细胞抑制作用的逆转。分别以1×102~5细胞/孔数量的“第三者”脂肪干细胞或经IFNγ作用后脂肪干细胞加入混合双向淋巴细胞反应体系中,观察淋巴细胞增殖抑制情况。结果脂肪干细胞表达HLAI类分子,但未检测到HLAII类分子阳性表达。人IFNγ刺激48h后,HLAI表达未见明显增高,HLAII类分子表达明显增高。异体或经IFNγ作用的脂肪干细胞均未能刺激淋巴细胞体外增殖。脂肪干细胞可明显抑制PHA刺激的淋巴细胞增殖,IL2可逆转脂肪干细胞的抑制作用。脂肪干细胞可明显抑制双相混合淋巴细胞反应,抑制作用呈脂肪干细胞细胞数量依赖性;经IFNγ作用后抑制作用未见明显减弱。结论ADSC可在体外抑制淋巴细胞增殖反应,具有一定的调节淋巴细胞反应的能力,有可能成为组织工程或细胞治疗中同种异体细胞来源。

关 键 词:脂肪干细胞 体外抑制 分子表达 实验研究 HLAII类分子 混合淋巴细胞反应 淋巴细胞增殖反应 细胞增殖情况 IFN-γ 流式细胞仪检测 细胞抑制作用 细胞增殖抑制 细胞体外增殖 免疫分子 细胞来源 同种异体 组织工程 反应体系

Human adipose derived stem cells suppress lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
Cui Lei,Yin Shuo,Yang Ping,Liu Bo,Zhang Ying,Liu Wei,Cao Yi-lin. Human adipose derived stem cells suppress lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli[J]. Zhonghua yi xue za zhi, 2005, 85(27): 1890-1894
Authors:Cui Lei  Yin Shuo  Yang Ping  Liu Bo  Zhang Ying  Liu Wei  Cao Yi-lin
Affiliation:Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Second Medical University, Shanghai Tissue Engineering Research and Development Center, Shanghai 200011, China.
Abstract:OBJECTIVE: To study immunological properties of adipose derived stem cells (ADSC) and their in vitro immunomodulatory effects on lymphocytes. METHODS: ADSC was isolated from fat tissue by liposuction and culture expanded. Cells at passage 2 were observed for the expression of HLAI, HLAII by FACs analysis. Peripheral blood lymphocytes (PBL) were cultured with allogeneic ADSCs at dose of 1 x 10(5). A third-party ADSCs at dose of 1 x 10(2), 1 x 10(3), 1 x 10(4), 1 x 10(5) were added to the ongoing two-way mixed lymphocyte reactions (MLR) for 6 days. Value of CPM (count per minute) was calculated with luminenscence counter. RESULTS: Flow cytometry showed that undifferentiated ADSCs express HLA class I but not class II. Addition of interferon gamma (IFN-gamma) for 48 hours induced greater than 90% of cells to express HLA class II. No lymphocyte response was induced by allogeneic ADSCs as stimulators. Results were similar using ADSCs pretreated with IFN-gamma. ADSCs elicited inhibit function of mixed lymphocyte cultures in a dose dependent way. Even if ADSCs were pretreated with IFN-gamma, the suppression ability was maintained. CONCLUSION: Undifferentiated ADSCs do not elicit alloreactive lymphocyte proliferative responses and could modulate immune responses in vitro.
Keywords:Stem cells  HLA antigens  Lymphocyte culture test  mixed
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号